HSIL, HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Clinical trials for HSIL, HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION explained in plain language.
Never miss a new study
Get alerted when new HSIL, HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION trials appear
Sign up with your email to follow new studies for HSIL, HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a probiotic fight anal cancer in HIV patients?
Disease control Not yet recruitingThis study tests whether a probiotic called EXE-346 can help treat anal high-grade squamous intraepithelial lesions (HSIL) and reduce persistent high-risk HPV infection in people living with HIV. The trial will enroll 90 participants who will take the probiotic or a placebo daily…
Matched conditions: HSIL, HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Light therapy could replace surgery for cervical precancer
Disease control Not yet recruitingThis study compares a light-activated gel treatment (ALA-PDT) to standard surgery (LEEP) for women with high-grade cervical precancer (HSIL/CIN2). About 560 women will receive either the gel plus red light therapy or surgery. The goal is to see if the gel treatment works as well …
Matched conditions: HSIL, HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC